Hypertrophic cardiomyopathy mutations increase myofilament Ca(2+) buffering, alter intracellular Ca(2+) handling, and stimulate Ca(2+)-dependent signaling

肥厚型心肌病突变会增加肌丝对Ca(2+)的缓冲能力,改变细胞内Ca(2+)的处理,并刺激Ca(2+)依赖性信号传导。

阅读:2

Abstract

Mutations in thin filament regulatory proteins that cause hypertrophic cardiomyopathy (HCM) increase myofilament Ca(2+) sensitivity. Mouse models exhibit increased Ca(2+) buffering and arrhythmias, and we hypothesized that these changes are primary effects of the mutations (independent of compensatory changes) and that increased Ca(2+) buffering and altered Ca(2+) handling contribute to HCM pathogenesis via activation of Ca(2+)-dependent signaling. Here, we determined the primary effects of HCM mutations on intracellular Ca(2+) handling and Ca(2+)-dependent signaling in a model system possessing Ca(2+)-handling mechanisms and contractile protein isoforms closely mirroring the human environment in the absence of potentially confounding remodeling. Using adenovirus, we expressed HCM-causing variants of human troponin-T, troponin-I, and α-tropomyosin (R92Q, R145G, and D175N, respectively) in isolated guinea pig left ventricular cardiomyocytes. After 48 h, each variant had localized to the I-band and comprised ∼50% of the total protein. HCM mutations significantly lowered the K(d) of Ca(2+) binding, resulting in higher Ca(2+) buffering of mutant cardiomyocytes. We observed increased diastolic [Ca(2+)] and slowed Ca(2+) reuptake, coupled with a significant decrease in basal sarcomere length and slowed relaxation. HCM mutant cells had higher sodium/calcium exchanger activity, sarcoplasmic reticulum Ca(2+) load, and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) activity driven by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) phosphorylation of phospholamban. The ryanodine receptor (RyR) leak/load relationship was also increased, driven by CaMKII-mediated RyR phosphorylation. Altered Ca(2+) homeostasis also increased signaling via both calcineurin/NFAT and extracellular signal-regulated kinase pathways. Altered myofilament Ca(2+) buffering is the primary initiator of signaling cascades, indicating that directly targeting myofilament Ca(2+) sensitivity provides an attractive therapeutic approach in HCM.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。